Dr. Brian Mark Keegan, MD

Dr. Keegan practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Keegan's NPI, 1659345130, was assigned on February 14, 2006. Dr. Keegan graduated from University Saskatchewan Royal Hospital in 1994. Dr. Keegan's Minnesota license number on file is 42324.

Dr. Keegan's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Keegan's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Keegan to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keegan practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Keegan's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Keegan is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Keegan's licenses on file in 15 states: Minnesota, New Hampshire, South Dakota, Iowa, Montana, Michigan, Connecticut, Illinois, Missouri, Oklahoma, Wisconsin, Idaho, Kentucky, North Dakota and New York.

Dmand AI lists carpal tunnel syndrome, lower back pain, migraine and chronic headache, multiple sclerosis, neck pain and spine problems, nerve damage, neuropathy and sleep apnea among the conditions Dr. Keegan treats.

CMS data shows 191 Medicare services from Dr. Keegan across 5 procedure codes in 2024, for 159 Medicare patients. Medicare paid $22,550 for them. Every service was in an office.

CMS counts 159 Medicare patients who saw Dr. Keegan in 2024. The largest group is 65 to 74, with 90 patients. 67% of them have high blood pressure, and 63% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keegan's median patient age at 58, with 66% women.

In 2024, Dr. Keegan wrote 74 Medicare Part D claims for 16 patients. 76% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $74,893 in total drug cost. In 2023, CMS named 51 claims across 4 drugs.

Dr. Keegan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Keegan as offering telehealth.

Dmand AI links 55 papers to Dr. Keegan, published from 2011 to 2022. 2019 was the busiest year, with 5. The most frequent topics are Magnetic Resonance Imaging, Disease Progression and Multiple Sclerosis. Dr. Keegan has published most often in Neurology. Dr. Keegan's most frequent co-authors are Eoin Paul Flanagan, MBCHB, Orhun H. Kantarci, MD and Sean J. Pittock, MD.

CMS Open Payments shows 7 general payments to Dr. Keegan from 3 drug and device companies from 2016 to 2020. Travel and lodging make up the largest share, 82% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,269.

Dr. Keegan graduated from University Saskatchewan Royal Hospital in 1994.

Dr. Keegan is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.